New melanocortin 1 receptor binding motif based on the C-terminal sequence of α-melanocyte-stimulating hormone

Basic and Clinical Pharmacology and Toxicology

Volumn 99, Issue 4, 2006, Pages 287-293

  Schiöth, Helgi B ^a   Muceniece, Ruta ^b   Mutule, Ilga ^c   Wikberg, Jarl E S ^a  

^a UPPSALA UNIVERSITY   (Sweden)

^b UNIVERSITY OF LATVIA   (Latvia)

^c LATVIAN INSTITUTE OF ORGANIC SYNTHESIS   (Latvia)

Author keywords

[No Author keywords available]

Indexed keywords

ACYLLYSYLPROLYLVALYLTYROSINAMIDE; ACYLTYROSYLLYSYLPROLYLVALINAMIDE; ALPHA INTERMEDIN; ALPHA INTERMEDIN DERIVATIVE; ALPHA MELANOCYTE STIMULATING HORMONE[11-13]; HS 401; HS 402; MELANOCORTIN 1 RECEPTOR; PROTEIN HS401; PROTEIN HS402; TETRAPEPTIDE; TRYPTOPHAN; TYROSINE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; DRUG BINDING; DRUG SYNTHESIS; HORMONE DETERMINATION; HORMONE RECEPTOR INTERACTION; HORMONE RELEASE; HUMAN; HUMAN CELL; HUMAN TISSUE; INSECT CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN MOTIF; RECEPTOR BINDING; STRUCTURE ACTIVITY RELATION;

AMINO ACID MOTIFS; ANIMALS; BINDING, COMPETITIVE; CERCOPITHECUS AETHIOPS; COS CELLS; HUMANS; MELANOCYTE-STIMULATING HORMONES; MELANOMA, EXPERIMENTAL; MICE; PROTEIN CONFORMATION; RECEPTOR, MELANOCORTIN, TYPE 1;

INSECTA;

EID: 33750045180     PISSN: 17427835     EISSN: 17427843     Source Type: Journal    
DOI: 10.1111/j.1742-7843.2006.pto_459.x     Document Type: Article

References (42)

1. 5 receptors. Eur. J. Pharmacol. 1994, 269, 331-337.
2. Al-Obeidi, F., A. L. Castrucci, M. E. Hadley & V. J. Hruby: Potent and prolonged acting cyclic lactam analogues of α-melanotropin-;design based on molecular dynamics. J. Med. Chem. 1989, 32, 2555-2561.
3. Catania, A., S. Gatti, G. Colombo & J. M. Lipton: Targeting melanocortin receptors as a novel strategy to control inflammation. Pharmacol. Rev. 2004, 56, 1-29.
4. 3. J. Peptide Res. 2005, 66, 19-26.
5. Cutuli, M., S. Cristiani, J. M. Lipton & A. Catania: Antimicrobial effects of α- MSH peptides. J. Leucoc. Biol. 2000, 67, 233-239.
6. Deeter, L. R., L. W. Martin & J. M. Lipton: Antipyretic properties of centrally administered alpha-MSH fragments in the rabbit. Peptides 1988, 9, 1285-1288.
7. Eberle, A. N.: The melanotropins. In: Chemistry, physiology and mechanisms of action. S. Karger, Basel, 1988.
8. Elliott, R. J, M. Szabo, M. J. Wagner, E. H. Kemp, S. MacNeil & J. W. Haycock: Alpha-Melanocyte-stimulating hormone, MSH 11-13 KPV and adrenocorticotropic hormone signaling in human keratinocyte cells. J. Invest. Dermatol. 2004, 122, 1010-1019.
9. Fredriksson, R., M. C. Lagerstrom, L. G. Lundin & H. B. Schioth: The G-protein-coupled receptors in the human genome form five main families. Phylogenetic analysis, paralogon groups, and fingerprints. Mol. Pharmacol. 2003, 63, 1256-1272.
10. Getting, S. J., H. B. Schiöth & M. Perretti: Dissection of the anti-inflammatory effect of the core and C-terminal (KPV) {alpha}-melanocyte stimulating hormone peptides. J. Pharmacol. Exp. Therap. 2003, 306, 631-637.
11. 193-195 receptor antagonism in the alveolar epithelium. Biochem. J. 2001, 355, 29-38.
12. Haskell-Luevano, C.: Physiology and chemistry of the melanocortin pathway. Peptides 2006, 27, 257-258.
13. Herpin, T. F, G. Yu, K. E. Carlson, G. C. Morton, X. Wu, L. Kang, H. Tuerdi, A. Khanna, J. S. Tokarski, R. M. Lawrence & J. E. Macor: Discovery of tyrosine-based potent and selective melanocortin-1 receptor small-molecule agonists with anti-inflammatory properties. J. Med. Chem. 2003, 46, 1123-1126.
14. Hiltz, M. E, A. Catania & J. M. Lipton: Anti-inflammatory activity of α-MSH(11-13) analogs: Influences of alteration in stereochemistry. Peptides 1991, 12, 767-771.
15. Hiltz, M. E. & J. M. Lipton: Antiinflammatory activity of a COOH-terminal fragment of the neuropeptide alpha-MSH. FASEB J. 1989, 3, 2282-2284.
16. Holder, J. R., Z. Xiang, R. M. Bauzo & C. Haskell-Luevano: Structure-activity relationships of the melanocortin tetrapeptide Ac-His-D-Phe-Arg-Trp-NH2 at the mouse melanocortin receptors. 4. Modifications at the Trp position. J. Med. Chem. 2002, 45, 5736-5744.
17. 2 with bulky aromatic amino acids at position 7 show high antagonist potency and selectivity at specific melanocortin receptors. J. Med. Chem. 1995, 38, 3454-3461.
18. Irani, B. G, J. R. Holder, A. Todorovic, A. M. Wilczynski, C. G. Joseph, K. R. Wilson & C. Haskell-Luevano: Progress in the development of melanocortin receptor selective ligands. Curr. Pharm. Des. 2004, 10, 3443-3479.
19. Irani, B. G & C. Haskell-Luevano: Feeding effects of melanocortin ligands - a historical perspective. Peptides 2005, 26, 1788-1799.
20. Kelly, J. M., A. J. Moir, K. Carlson, Y. Yang, S. Macneil & J. W. Haycock: Immobilized alpha-melanocyte-stimulating hormone 10-13 (GKPV) inhibits tumor necrosis factor-alpha stimulated NF-kappaB activity. Peptides 2006, 27, 431-437.
21. Lipton, J. M. & A. Catania: Anti-inflammatory actions of the neuroimmunomodulator - α-MSH. Immunol. Today, 1997, 18, 140-145.
22. Lyson, K., G. Ceriani, A. Takashima, A. Catania & J. M. Lipton: Binding of anti-inflammatory alpha-melanocyte-stimulating-hormone peptides and proinflammatory cytokines to receptors on melanoma cells. Neuroimmunomodulation 1994, 1, 121-126.
23. Mandrika, I., R. Muceniece & J. E. S. Wikberg: Effects of melanocortin peptides on lipopolysaccharide/interferon-gamma-induced NF-kappaB DNA binding and nitric oxide production in macrophage-like RAW 264.7: evidence for dual mechanisms of action. Biochem. Pharmacol. 2001, 61, 613-621.
24. Moustafa, M., M. Szabo, G. E. Ghanem, R. Morandini, E. H. Kemp, N. S. Mac & J. W. Haycock: Inhibition of tumor necrosis factor-alpha stimulated NFkappaB/p65 in human keratinocytes by alpha-melanocyte stimulating hormone and adrenocorticotropic hormone peptides. J. Invest. Dermatol. 2002, 119, 1244-1253.
25. Muceniece, R., L. Krigere, H. Süli-Vargha & J. E. S. Wikberg: Effects of α-melanotropin C-terminal tripeptide analogues on macrophage NO production. Peptides 2003, 24, 701-707.
26. Nordstedt, C. & B. B. Fredholm: A modification of a protein-binding method for rapid quantification of cAMP in cell-culture supernatants and body fluid. Anal. Biochem. 1990, 189, 231-234.
27. O'Reilly, D. R., L. K. Miller & V. A. Luckow: Baculovirus expression vectors: A laboratory manual. Freeman, New York, 1992.
28. Prusis, P., H. B. Schiöth, R. Muceniece, P. Herzyk, M. Afshar, R. E. Hubbard & J. E. S. Wikberg: Modelling of the three-dimensional structure of the human melanocortin1 receptor, using an automated method and docking of a rigid cyclic melanocyte-stimulating hormone core peptide. J. Mol. Graphics Modelling 1997, 15, 307-317.
29. Prusis, P., R. Muceniece, I. Mutule, F. Mutulis & J. E. Wikberg: Design of new small cyclic melanocortin receptor-binding peptides using molecular modeling: Role of the His residue in the melanocortin peptide core. Eur. J. Med. Chem. 2001, 36, 137-146.
30. Quillan, J. M. & W. Sadee: Structure-based search for peptide ligands that cross-react with melanocortin receptors. Pharm. Res. 1996, 13, 1624-1630.
31. Richards, D. B. & J. M. Lipton: Effect of alpha-MSH 11-13 (lysine-proline-valine) on fever in the rabbit. Peptides 1984, 5, 815-817.
32. Sawyer, T. K., P. J. Sanfilippo, V. J. Hruby, M. H. Engel, C. B. Heward, J. B. Bernet & M. E. Hadley: {Nle4, D-Phe7} α-melanocyte stimulating hormone: A highly potent α-melanotropin with ultralong biological activity. Proc. Natl. Acad. Sci. USA 1980, 77, 5754-5758.
33. Sawyer, T. K., D. J. Staples, A. M. L. Castrucci, M. E. Hadley, A. Al-Obeidi, W. L. Cody & V. J. Hruby: α-Melanocyte stimulating hormone message and inhibitory sequences: comparative structure-activity studies on melanocytes. Peptides 1990, 11, 351-357.
34. Schiöth, H. B., A. Kuusinen, R. Muceniece, M. Szardenings, K. Keinanen & J. E. S. Wikberg: Expression of the functional melanocortin receptor 1 receptors in insect cells. Biochem. Biophys. Res. Commun. 1996a, 221, 807-814.
35. Schiöth, H., R. Muceniece & J. E. S. Wikberg: Characterization of the melanocortin 4 receptor radioligand binding. Pharmacology & Toxicology 1996b, 79, 161-165.
36. Schiöth, H. B., R. Muceniece, M. Larsson, F. Mutulis, M. Szardenings, P. Prusis, G. Lindeberg & J. E. S. Wikberg: Binding of cyclic and linear MSH core peptides to the melanocortin receptor subtypes. Eur. J. Pharmacol. 1997, 319, 369-373.
37. Schiöth, H. B., T. Haitina, M. K. Ling, A. Ringholm, R. Fredriksson, J. M. Cerda-Reverter & J. Klovins: Evolutionary conservation of the structural, pharmacological, and genomic characteristics of the melanocortin receptor subtypes. Peptides 2005, 26, 1886-900.
38. Schiöth, H. B.: The physiological role of melanocortin receptors. Vitam. Horm. 2001, 63, 195-232.
39. Todorovic, A. & C. Haskell-Luevano: A review of melanocortin receptor small molecule ligands. Peptides 2005, 26, 2026-2036.
40. Uehara, Y., H. Shimizu, N. Sato, Y. S. Mura & M. Mori: The dipeptide Lys-Pro attenuates interleukin-1 beta-induced anorexia. Peptides 1993, 14, 175-178.
41. Wikberg, J. E. S.: Melanocortin receptors: new opportunities in drug discovery. Exp. Opin. Ther. Patents 2001, 11, 61-76.
42. Wikberg, J. E. S., R. Muceniece, I. Mandrika, P. Prusis, J. Lindblom, C. Post & A. Skottner: New aspects on the melanocortins and their receptors. Pharmacol. Res. 2000, 42, 393-420.